MedPath

Continuous Glucose Monitoring in menstruating women with Type 2 Diabetes

Not Applicable
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2022/10/046121
Lead Sponsor
Smitha Bhat
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Women with Type 2 diabetes as per ADA criteria , between the ages of 20 and 45 , with regular ( ovulatory) menstrual cycles

Exclusion Criteria

a.Women with irregular menstrual cycles

b.Women taking hormonal contraception

c.Pregnancy

d.Breast feeding mothers

e.Thyroid function abnormality

f. Untreated or inadequately treated hypothyroidism.

g.HbA1C > 8

h.eGFR <6o ml/min/1.73 m2

i.Prednisone use for more than 10 days during the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
a. Primary outcome measures ââ?¬â?? estimate of glycemic variability in women in different phases of menstrual cycle <br/ ><br>Timepoint: at end of trial <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Secondary outcome measures ââ?¬â?? association of glycemic variability with parameters of insulin resistance and sex steroid levels <br/ ><br>Timepoint: at end of trial
© Copyright 2025. All Rights Reserved by MedPath